PlusTherapeuticsInc . (NASDAQ:PSTV) Trading 9.5% Higher

PlusTherapeuticsInc . (NASDAQ:PSTV)’s share price traded up 9.5% during mid-day trading on Friday . The company traded as high as $8.70 and last traded at $8.30, 176,256 shares were traded during trading. An increase of 28% from the average session volume of 138,160 shares. The stock had previously closed at $7.58.

The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.37 and a current ratio of 0.38.

PlusTherapeuticsInc . (NASDAQ:PSTV) last released its quarterly earnings data on Thursday, August 15th. The company reported ($5.12) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($9.75) by $4.63. The firm had revenue of $0.30 million for the quarter. PlusTherapeuticsInc . had a negative net margin of 492.45% and a negative return on equity of 546.87%.

About PlusTherapeuticsInc . (NASDAQ:PSTV)

Plus Therapeutics, Inc, a clinical-stage pharmaceutical company, engages in developing treatments for cancer and other diseases in the United States. The company's lead product candidate in pipeline is DocePLUS, an albumin-stabilized PEGylated liposomal formulation of docetaxel for the treatment of small cell lung cancer.

Featured Story: What is the Coverage Ratio?

Receive News & Ratings for PlusTherapeuticsInc . Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PlusTherapeuticsInc . and related companies with MarketBeat.com's FREE daily email newsletter.